Inventor · disambiguated record
Leland W.K. Chung
Also filed as: CHUNG LELAND · CHUNG LELAND W · CHUNG LELAND W K
17 granted patents·33 pending applications·282 citations·filing 1994–2024
93Inventor score
Files withDA ZEN THERANOSTICS INC10CEDARS SINAI MEDICAL CENTER9UNIV VIRGINIA7UNIV EMORY5CHUNG LELAND W K2
Top patents by PatentIndex Score
50 records- 0194US6572856B1Methods for the prevention and treatment of cancer using anti-C3b(i) antibodiesUNIV VIRGINIA·Filed 2000·Granted Jun 3, 2003·173 cites·46 claims
- 0292US10307489B2Organic anion transporting peptide-based cancer imaging and therapyDA ZEN THERANOSTICS INC·Filed 2015·Granted Jun 4, 2019·10 cites·18 claims
- 0382US9610370B2Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared propertiesCHUNG LELAND W K·Filed 2012·Granted Apr 4, 2017·7 cites·2 claims
- 0478US2025120947A1Compounds and methods to sensitize cancer cells to cisplatinDA ZEN THERANOSTICS INC·Filed 2024·Application pending·0 cites
- 0578US2023226198A1Artemisinin DerivativesDA ZEN THERANOSTICS INC·Filed 2023·Application pending·0 cites
- 0677US9771625B2Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancerSHIH JEAN C·Filed 2012·Granted Sep 26, 2017·7 cites·3 claims
- 0777US2023116399A1Tumor Homing Statin DerivativesDA ZEN THERANOSTICS INC·Filed 2022·Application pending·0 cites
- 0877US2024261263A1Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitorsDA ZEN THERANOSTICS INC·Filed 2023·Application pending·0 cites
- 0975US6342384B1Production of adenoviral vectors using serum-free suspension cell culture in a hollow fiber systemUNIV VA PATENT FOUNDATION·Filed 1998·Granted Jan 29, 2002·41 cites·2 claims
- 1074US2023248832A1Small Molecule Ligand-Drug Conjugates for Targeted Cancer TherapyUNIV EMORY·Filed 2023·Application pending·0 cites
- 1173US12414996B2Organic anion transporting peptide-based cancer imaging and therapyDA ZEN THERANOSTICS INC·Filed 2021·Granted Sep 16, 2025·0 cites·18 claims
- 1271US2011085974A1Small molecule ligand-drug conjugates for targeted cancer therapyCEDARS SINAI MEDICAL CENTER·Filed 2009·Application pending·0 cites
- 1370US6596534B1Utilization of osteocalcin promoter to deliver therapeutic genes to tumorsUNIV VIRGINIA·Filed 2000·Granted Jul 22, 2003·2 cites·9 claims
- 1466US2021046048A1Artemisinin DerivativesDA ZEN THERANOSTICS INC·Filed 2020·Application pending·0 cites
- 1566US2019240342A1Organic anion transporting peptide-based cancer imaging and therapyDA ZEN THERANOSTICS INC·Filed 2019·Application pending·0 cites
- 1665US9745578B2Targeting microRNA miR-409-3P to treat prostate cancerCEDARS SINAI MEDICAL CENTER·Filed 2015·Granted Aug 29, 2017·1 cites·8 claims
- 1765US2021008217A1Tumor Homing Statin DerivativesDA ZEN THERANOSTICS INC·Filed 2020·Application pending·0 cites
- 1864US2011262354A1Cyanine-containing compounds for cancer imaging and treatmentUNIV EMORY·Filed 2008·Application pending·0 cites
- 1962US11738095B2Cyanine-containing compounds for cancer imaging and treatmentUNIV EMORY·Filed 2017·Granted Aug 29, 2023·0 cites·22 claims
- 2061US12121510B2Compounds and methods to sensitize cancer cells to cisplatinCEDARS SINAI MEDICAL CENTER·Filed 2017·Granted Oct 22, 2024·0 cites·19 claims
- 2161US11878000B2Compounds and methods to sensitize cancer cells to tyrosine kinase inhibitorsCEDARS SINAI MEDICAL CENTER·Filed 2017·Granted Jan 23, 2024·0 cites·21 claims
- 2257US5772993AOsteocalcin promoter-based toxic gene therapy for the treatment of calcified tumors and tissuesUNIV VIRGINIA·Filed 1997·Granted Jun 30, 1998·11 cites·6 claims
- 2356US2016310604A1Small molecule ligand-drug conjugates for targeted cancer therapyCEDARS SINAI MEDICAL CENTER·Filed 2016·Application pending·0 cites
- 2456US2010015148A1Methods and compositions for the utilization and targeting of osteomimicryDA ZEN GROUP LLC·Filed 2008·Application pending·0 cites
- 2554US2024307560A1Heptamethine carbocyanine dye-dota conjugates complexed with lutetium-177, yttrium-90, or gallium-68, and their uses for image-guided radiotherapyDA ZEN THERANOSTICS INC·Filed 2021·Application pending·0 cites
- 2653US5728815ABone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasisUNIV TEXAS·Filed 1994·Granted Mar 17, 1998·14 cites·15 claims
- 2753US2015335765A1Cyanine-containing compounds for cancer imaging and treatmentUNIV EMORY·Filed 2015·Application pending·0 cites
- 2852US2021113715A1Targeted nanoparticles for diagnosing, detecting and treating cancerCEDARS SINAI MEDICAL CENTER·Filed 2019·Application pending·0 cites
- 2952US2015183736A1Cyanine-containing compounds for cancer imaging and treatmentUNIV EMORY·Filed 2015·Application pending·0 cites
- 3052US2011142848A1Anti-beta-2-microglobulin agents and the use thereofCHUNG LELAND W K·Filed 2009·Application pending·0 cites
- 3151US6159467AIn vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapyUNIV VIRGINIA·Filed 1998·Granted Dec 12, 2000·12 cites·10 claims
- 3251US2017314056A1Method of using near infrared fluorescent dyes for imaging and targeting cancersYANG XIAOJIAN·Filed 2017·Application pending·0 cites
- 3350US2004228860A1Antibodies to a tumor-associated surface antigen for delivery of diagnostic and therapeutic agentsUNIV VIRGINIA·Filed 2003·Application pending·0 cites
- 3449US2002052041A1Production of adenoviral vectors using serum-free suspension cell culture in a hollow fiber systemUNIV VIRGINIA·Filed 2001·Application pending·0 cites
- 3547US2007078085A1Methods and compositions for the utilization and targeting of osteomimicryCHUNG LELAND W·Filed 2005·Application pending·0 cites
- 3646US2013263297A1Methods of treating cancerCEDARS SINAI MEDICAL CENTER·Filed 2013·Application pending·0 cites
- 3746US2010144678A1Compositions and methods for treating bone cancerUNIV COLORADO REGENTS·Filed 2008·Application pending·0 cites
- 3845US2013101513A1Method of using near infrared fluorescent dyes for imaging and targeting cancersYANG XIAOJIAN·Filed 2011·Application pending·0 cites
- 3945US2015276748A1Methods of prognosticating and treating cancerCEDARS SINAI MEDICAL CENTER·Filed 2013·Application pending·0 cites
- 4045US2021128731A1Nanoparticles for boron neutron capture therapy and for diagnosing, detecting, and treating cancerCEDARS SINAI MEDICAL CENTER·Filed 2019·Application pending·0 cites
- 4144US2007015149A1Prlz regulatory elements in the treatment of disease and the discovery of therapeuticsWANG RUOXING·Filed 2003·Application pending·0 cites
- 4244US2018185303A1Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancerUNIV SOUTHERN CALIFORNIA·Filed 2017·Application pending·0 cites
- 4341US10823736B2Method of assessing disease condition of cancerUNIV CALIFORNIA·Filed 2015·Granted Nov 3, 2020·0 cites·23 claims
- 4439US2003078224A1Gene expression directed by a super-PSA promoterFiled 2002·Application pending·0 cites
- 4538US2004101840A1Identification, cloning and characterization of a novel pc-1 gene differentially expressed in prostate cells and tissuesFiled 2001·Application pending·0 cites
- 4637US5679636ABone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasisUNIV TEXAS·Filed 1994·Granted Oct 21, 1997·4 cites·1 claims
- 4736US2002025307A1Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissuesFiled 2001·Application pending·0 cites
- 4831US2014323551A1Targeting micrornas mir-409-5p, mir-379 and mir-154* to treat prostate cancer bone metastasis and drug resistant lung cancerCEDARS SINAL MEDICAL CT·Filed 2012·Application pending·0 cites
- 4926US2001038834A1Bone cancer therapyFiled 1998·Application pending·0 cites
- 5023US5874305AAndrogen-repressed metastatic human prostate cancer cell lineUNIV VIRGINIA·Filed 1996·Granted Feb 23, 1999·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Leland W.K. Chung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →